Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole adjunctive therapy with lithium or valproate for acute mania in bipolar I disorder
2004-000202-49Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aripiprazole in bipolar I disorder (4 arms), sponsored by Bristol Myers Squibb. Primary endpoint: Primary efficacy endpoint. Started Feb 2005; status: completed.
02
Drugs
aripiprazole
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2004-000202-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000202-49.